Condom use and the risk of recurrent pelvic inflammatory disease, chronic pelvic pain, or infertility following an episode of pelvic inflammatory disease

American Journal of Public Health

Volumn 94, Issue 8, 2004, Pages 1327-1329

  Ness, Roberta B ^a   Randall, Hugh ^b   Richter, Holly E ^c   Peipert, Jeffrey F ^d   Montagno, Andrea ^d   Soper, David E ^e   Sweet, Richard L ^a,c   Nelson, Deborah B ^f   Schubeck, Diane ^g   Hendrix, Susan L ^h   Bass, Debra C ^a   Kip, Kevin E ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b EMORY UNIVERSITY   (United States)

^c UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^d WOMEN AND INFANTS HOSPITAL   (United States)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g METROHEALTH MEDICAL CENTER   (United States)

^h WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEDROXYPROGESTERONE; ORAL CONTRACEPTIVE AGENT; SPERMICIDAL AGENT;

ADOLESCENT; ADULT; ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONDOM; FEMALE; FEMALE INFERTILITY; FOLLOW UP; GONORRHEA; HORMONAL CONTRACEPTION; HUMAN; INTERVIEW; INTRAUTERINE CONTRACEPTIVE DEVICE; LEUKORRHEA; MAJOR CLINICAL STUDY; NEISSERIA GONORRHOEAE; ORAL CONTRACEPTION; PELVIC INFLAMMATORY DISEASE; PELVIS PAIN SYNDROME; RECURRENT DISEASE; SELF REPORT; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; UTERINE CERVICITIS;

EID: 3442895616     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.94.8.1327     Document Type: Article

References (24)

1. National Survey of Family Growth. In: Vital and Health Statistics: Data From the National Survey of Family Growth. Hyattsville, Md: Public Health Service, National Center for Health Statistics; 1995.
2. Westrom L. Incidence, prevalence, and trends of acute pelvic inflammatory disease and its consequences in industrialized countries. Am J Obstet Gynecol. 1980;138:880-892.
3. Westrom L, Joesoef R, Reynolds G, Hagdu A, Thompson SE. Pelvic inflammatory disease and fertility: a cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex Transm Dis. 1992;19:185-192.
4. Westrom L, Eschenbach D. Pelvic inflammatory disease. In: Holmes K, Mardh P, Sparling P, et al, eds. Sexually Transmitted Diseases. 3rd ed. New York, NY: McGraw-Hill; 1999:783-809.
5. Eng TR, Butler WT, eds. The Hidden Epidemic: Confronting Sexually Transmitted Disease. Washington, DC: Committee on Prevention and Control of Sexually Transmitted Diseases, Institute of Medicine, National Academy Press; 1997.
6. Workshop summary: scientific evidence on condom effectiveness for sexually transmitted disease (STD) prevention. Paper presented at: National Institute of Allergy and Infectious Diseases, National Institutes of Health; 2000: Herndon, Va.
7. Mann JR, Stine CC, Vessey J. The role of disease-specific infectivity and number of disease exposures on long-term effectiveness of the latex condom. Sex Transm Dis. 2002;29:344-349.
8. Cates W. The condom forgiveness factor: the positive spin. Sex Transm Dis. 2002;29:350-352.
9. Ness RB, Soper DE, Holley RL, et al. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) randomized trial. Am J Obstet Gynecol. 2002;186:929-937.
10. Ness RB, Soper DE, Peipert J, et al. Design of the PID Evaluation and Clinical Health (PEACH) Study. Control Clin Trials. 1998;19:499-513.
11. Rosenberg MJ, Davidson AJ, Chen JH, Judson FN, Douglas JM. Barrier contraceptives and sexually transmitted diseases in women: a comparison of female-dependent methods and condoms. Am J Public Health. 1992;82:669-674.
12. Austin H, Louv WC, Alexander J. A case-control study of spermicides and gonorrhea. JAMA. 1984;251:2822-2824.
13. Peters SE, Beck-Sague CM, Farshy CE, et al. Behaviors associated with Neisseria gonorrhoeae and Chlamydia trachomatis: cervical infection among young women attending adolescent clinics. Clin Pediatr (Phila). 2000;39:173-177.
14. Gaydos CA, Howell MR, Pare B, et al. Chlamydia trachomatis infections in female military recruits. N Engl J Med 1998;339:739-744.
15. Radcliffe DW, Ahmad S, Gilleran G, Ross JDC. Demographic and behavioural profile of adults infected with Chlamydia: a case-control study. Sex Transm Infect. 2001;77:265-270.
16. Zenilman JM, Weisman CS, Rompalo AM, et al. Condom use to prevent incident STDs: the validity of self-reported condom use. Sex Transm Dis. 1995;22:15-21.
17. Joesoef MR, Linnan M, Barakbah Y, Idajadi A, Kambodji A, Schulz K. Patterns of sexually transmitted diseases in female sex workers in Surabaya, Indonesia. Int J STD AIDS. 1997;8:576-580.
18. Paris M, Gotuzzo E, Goyzueta G, et al. Prevalence of gonococcal and chlamydial infections in commercial sex workers in a Peruvian Amazon City. Sex Transm Dis. 1999;26:103-107.
19. Fortenberry JD, Brizendine EJ, Katz BP, Wools KK, Blythe MJ, Orr DP. Subsequent sexually transmitted infections among adolescent women with genital infection due to Chlamydia trachomatis, Neisseria gonorrhoeae, or Trichomonas vaginalis. Sex Transm Dis. 1999;26:26-32.
20. Kelaghan J, Rubin GL, Ory HW, et al. Barrier-method contraceptives and pelvic inflammatory disease. JAMA. 1982;248:184-187.
21. Cramer DW, Goldman MB, Schiff I, et al. The relationship of tribal infertility to barrier method and oral contraceptive use. JAMA, 1987;257:2446-2450.
22. Ness RB, Soper DE, Holley RL, et al. Hormonal and barrier contraception and risk of upper genital tract disease in the PID Evaluation and Clinical Health (PEACH) Study. Am J Obstet Gynecol. 2001;185:121-127.
23. Ellish NJ, Weisman CS, Celentano D, Zenilman JM. Reliability of partner reports of sexual history in a heterosexual population at a sexually transmitted disease clinic. Sex Transm Dis. 1996;23:446-452.
24. Centers for Disease Control and Prevention. Nonoxynol-9 spermicide contraception use-United States, 1999. MMWR Morb Mortal Wkly Rep. 2002;51:389-392.